Group 1 - The company has signed two memorandums of understanding (MOUs) to explore new business opportunities in blockchain technology and digital innovation [1][2] - The first MOU is with Supernova, focusing on developing and managing blockchain-based systems and related token issuance under applicable U.S. laws, as well as representing Supernova in projects related to AQP functional water technology [1][2] - The second MOU is with Scaling Lab, aimed at collaborating on scientific research related to the genetic epidemiology and physiology of cardiovascular diseases and their risk factors, particularly diabetes [1][2] Group 2 - The company is actively seeking to diversify its revenue sources and enhance performance through strategic plans, including expanding into the blockchain technology sector [2] - The collaboration with Supernova is expected to facilitate entry into the digital innovation industry and develop a new business segment [2] - The partnership with Scaling Lab is intended to strengthen the company's diabetes solution development and support the exploration of new business opportunities [2]